Stock Taper
Sunshine Biopharma, Inc. develops anticancer drugs like Adva-27a and anti-coronavirus treatments, alongside nutritional supplements, focusing on innovative therapies for various cancers and resistant diseases.

A generic prescription drug launched in Canada to treat nausea and vomiting. Its recent regulatory approval and market introduction represent a significant commercial milestone for the company's revenue-generating generic pharmaceuticals division.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
NRSN | $0.47 | COMPARE |
BFRI | $1.27 | COMPARE |
LFWD | $7.68 | COMPARE |
PHIO | $1.04 | COMPARE |
INAB | $0.98 | COMPARE |
APVO | $4.18 | COMPARE |
RNAZ | $3.96 | COMPARE |
SBFM | $1.13 | COMPARE |